Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in Turkiye: Systematic review
- PMID: 37719251
- PMCID: PMC10500232
- DOI: 10.14744/nci.2022.17003
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in Turkiye: Systematic review
Abstract
The World Health Organization has designated carbapenem-resistant Acinetobacter baumannii (CRAB) as a "critical" pathogen on the global priority list of antibiotic-resistant bacteria. This study aims to discuss the molecular epidemiology of CRAB isolates in Turkiye in the last 12 years and the prevalence of gene regions associated with resistance or pathogenesis using a systematic review method. Our study consists of a literature search, determination of eligibility and exclusion criteria, qualitative analysis of studies, data extraction, and statistical analysis. All studies were analyzed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Guidelines. The incidence rates of blaOXA-23, blaOXA-23-like, blaOXA-24/40, blaOXA-24/40-like, blaOXA-51, blaOXA-51-like, blaOXA-58, and blaOXA-58-like genes in CRAB strains were 76.4%, 68.6%, 1.2%, 3.4%, 97.0%, 98.6%, 8.4%, and 17.1%, respectively. It was determined that the prevalence of the blaOXA-23 and blaOXA-58 gene regions showed a statistically significant change over the years. Due to the high prevalence of A. baumannii strains carrying the blaOXA-23 variant, it is necessary to follow its geographical distribution and transposon and plasmid movements. Based on available data, molecular surveillance of CRAB strains should be standardized. In addition, sterilization and disinfection processes applied within the scope of an effective struggle against CRAB strains that can remain live on surfaces for a long time should be reviewed frequently.
Keywords: Acinetobacter baumannii; blaoxa-23; blaoxa-24/40; blaoxa51; blaoxa58.
© Copyright 2023 by Istanbul Provincial Directorate of Health.
Conflict of interest statement
No conflict of interest was declared by the authors.
Figures
Similar articles
-
Molecular Epidemiology of Emerging blaOXA-23-Like- and blaOXA-24-Like-Carrying Acinetobacter baumannii in Taiwan.Antimicrob Agents Chemother. 2018 Feb 23;62(3):e01215-17. doi: 10.1128/AAC.01215-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29311067 Free PMC article.
-
Carbapenem-resistant Acinetobacter baumannii isolates carrying blaOXA genes with upstream ISAba1: First report of a novel OXA subclass from Iran.J Glob Antimicrob Resist. 2019 Sep;18:95-99. doi: 10.1016/j.jgar.2018.12.011. Epub 2019 Feb 11. J Glob Antimicrob Resist. 2019. PMID: 30763760
-
Spread of the blaOXA-23-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China.Front Microbiol. 2017 Feb 6;8:163. doi: 10.3389/fmicb.2017.00163. eCollection 2017. Front Microbiol. 2017. PMID: 28220115 Free PMC article.
-
A Systematic Review and Meta-Analysis of Molecular Characteristics on Colistin Resistance of Acinetobacter baumannii.Diagnostics (Basel). 2024 Nov 19;14(22):2599. doi: 10.3390/diagnostics14222599. Diagnostics (Basel). 2024. PMID: 39594265 Free PMC article. Review.
-
Does Emerging Carbapenem Resistance in Acinetobacter baumannii Increase the Case Fatality Rate? Systematic Review and Meta-Analysis.Infect Dis Rep. 2023 Sep 27;15(5):564-575. doi: 10.3390/idr15050055. Infect Dis Rep. 2023. PMID: 37888136 Free PMC article. Review.
Cited by
-
An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by acinetobacter baumannii-calcoaceticus complex: A narrative review.Health Sci Rep. 2024 Sep 9;7(9):e70066. doi: 10.1002/hsr2.70066. eCollection 2024 Sep. Health Sci Rep. 2024. PMID: 39257909 Free PMC article.
-
Molecular Epidemiology and Genetic Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates from the ICU of a Tertiary Hospital in East China.Infect Drug Resist. 2024 Dec 31;17:5925-5945. doi: 10.2147/IDR.S491858. eCollection 2024. Infect Drug Resist. 2024. PMID: 39759767 Free PMC article.
References
-
- Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41:11–9. - PubMed
-
- Maragakis LL, Perl TM. Acinetobacter baumannii epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–63. - PubMed
-
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81. - PubMed
-
- Abozahra R, Abdelhamid SM, Elsheredy AG, Abdulwahab KE, Baraka K. Genotyping and molecular characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from intensive care unit patients. Microbiol Biotechnol Lett. 2021;49:239–42.
Publication types
LinkOut - more resources
Full Text Sources